The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection.
To evaluate the impact of long-term purified FSH (pFSH) therapy in male partners before intracytoplasmic sperm injection (ICSI). Prospective, randomized, controlled study. Large university-based IVF unit. Seventy-eight patients made up the study and control groups (39 patients each). All patients had severe male factor infertility. Induction of ovulation, oocyte retrieval, ICSI, and ET were carried out in both groups. In the study group, male partners received pFSH (75 IU FSH, <1 IU LH) for > or = 50 days before oocyte retrieval. Fertilization rate, embryo quality, implantation and pregnancy rates. Fertilization and pregnancy rates were higher in the study group (68% and 35.9%, respectively) were higher than in the control group (59% and 17.9%, respectively), although the differences did not reach statistical significance. The implantation rate was significantly higher in the study group (15.5% versus 6.5%). The study group showed a trend toward a higher number of better-quality embryos per transfer (mean +/- SD, 2.2 +/- 1.6 versus 1.6 +/- 1.6). Purified FSH therapy in male partners before ICSI improves implantation rate. Improved embryo quality may be a contributory factor.